Skip to main content

GNMSF · Genmab A/S · Analyst Estimates

Track GNMSF — free
$378.00 -18.97 (-4.78%) At close · Oct 6
Market Cap
$21.72B
Shares
614.90M
Volume · Oct 6 37.32K Avg daily vol (3M) 2808

Analyst Estimates

Compare analyst forecasts for Genmab A/S across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-07 10:21 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.18
1.18
1.18
—
1.13
1.32
1.13
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
2
1
Revenue
DKK
Publication date not stated
28053043000
29474088000
31543443000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
19
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.53
1.53
1.53
—
1.59
1.88
1.59
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
1
0
1
1
Revenue
DKK
Publication date not stated
30782129310
34234913950
37829563000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
21
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.24
0.32996
0.41
—
0.33748
0.35156
0.33748
0.31929
— — — —
EPS
analysts
Publication date not stated
— — —
6
— — — —
2
1
2
0
Revenue
DKK
Publication date not stated
7531732000
7903930730
8310688000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.19
0.27343
0.4
—
0.3016
0.28571
0.3016
0.34738
— — — —
EPS
analysts
Publication date not stated
— — —
6
— — — —
2
0
2
1
Revenue
DKK
Publication date not stated
7756709520
8331123320
9777671000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
11
— — — — — — — —
Key facts CIK 1434265 CUSIP 372303206 Visit website Investor relations